CClinicalTrials.gg
CompletedNCT01053572Updated Apr 25, 2017

Role of Steroids and 10% Hypertonic Sodium Chloride in Adhesiolysis in Post Lumbar Surgery Syndrome Patients

An interventional study of Adhesiolysis in Low Back Pain, sponsored by Pain Management Center of Paducah. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-04-25.

Sponsored by Pain Management Center of Paducah · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
240
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

To evaluate the effectiveness of steroids and/or 10% hypertonic sodium chloride in percutaneous adhesiolysis in managing chronic low back and/or lower extremity pain in patients with post lumbar surgery syndrome.

To evaluate and compare the adverse event profile in all groups.

Read the detailed description

Recruitment is indicated in patients with chronic low back pain and lower extremity pain secondary to post lumbar laminectomy syndrome, non-responsive to conservative therapy with physical therapy, chiropractic, medical therapy, and fluoroscopically directed epidural injections.

This is a single-center, prospective, randomized, double-blind, equivalence, controlled trial performed in an interventional pain management referral center in the United States.

The study involves 240 patients studied in 4 groups with 60 patients in each group. Randomization includes sequence generation, allocation concealment, implementation, and blinding.

Data management analysis includes sample size justification of 40 patients in each group with a power of 80% and a 0.05% 2-sided significance level. Statistical methodology includes chi-squared statistics, Fisher's exact test, t-test, and paired t-test with significance evaluated at P value \< 0.05.

02

Conditions studied

  • Low Back Pain

Keywords

  • Chronic low back pain
  • Post lumbar laminectomy syndrome
  • Lower extremity pain
  • Local anesthetic
  • Steroid
  • Percutaneous lumbar adhesiolysis
03

In context

Back Pain

2,373 studies on the registry are indexed under Back Pain; 284 are open to participants now.

This study's enrollment of 240 is above the median of 60 across 1,941 interventional studies indexed under Back Pain.

Browse Back Pain studies →

Lead sponsor

Pain Management Center of Paducah is the lead sponsor of 14 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

Inclusion criteria:

  • History of lumbar surgery of at least 6 months duration in the past
  • Patients over the age of 18 years
  • Patients with a history of chronic function-limiting low back pain with or without lower extremity pain of at least 6 months duration (post-surgery)
  • Patients who are competent to understand the study protocol and provide voluntary, written informed consent and participate in outcome measurements.

Exclusion criteria:

  • Facet joints, uncontrollable as sole pain generators
  • Unstable or heavy opioid use (400 mg of morphine equivalents daily)
  • Uncontrolled psychiatric disorders
  • Uncontrolled medical illness
  • Any conditions that could interfere with the interpretation of the outcome assessments
  • Pregnant or lactating women
  • Patients with a history or potential for adverse reaction(s) to local anesthetic, steroids, or hypertonic sodium chloride solution.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Care provider)
Enrollment
240 participants (actual)

Study arms

  • Active comparator
    Celestone

    Group I will receive adhesiolysis, local anesthetic, 10% sodium chloride solution, and non-particulate Celestone

    Procedure: Adhesiolysis

  • Active comparator
    sodium chloride solution

    Group II will receive adhesiolysis, local anesthetic, 10% sodium chloride solution, and 0.9% sodium chloride solution to substitute for non-particulate Celestone

    Procedure: Adhesiolysis

  • Active comparator
    sodium choride solution

    Group III will receive adhesiolysis, local anesthetic, normal sodium chloride solution instead of 10% hypertonic sodium chloride solution and non-particulate Celestone;

    Procedure: Adhesiolysis

  • Active comparator
    Double substitutes

    Group IV will receive adhesiolysis, local anesthetic, and 0.9% sodium chloride solution to substitute for the 10% hypertonic sodium chloride, and 0.9% sodium chloride solution to substitute for non-particulate Celestone

    Procedure: Adhesiolysis

Interventions

  • ProcedureAdhesiolysis

    Group I will receive adhesiolysis, local anesthetic, 10% sodium chloride solution, and non-particulate Celestone

    Also known as: Adhesiolysis in post-surgery

06

What researchers measure

Primary outcomes

  1. Numeric rating scale (NRS), Oswestry Disability Index (ODI),

    duration of significant pain relief, opioid intake, and return to work

    Time frame: Outcomes are measured at baseline and at 3, 6, 12, 18, and 24 months post-treatment.

Secondary outcomes

  1. Adverse event profile of side effects and complications.

    Record side effects and any complications

    Time frame: Adverse events are measured at baseline and at 3, 6, 12, 18, and 24 months post-treatment, and at any time during the procedure or after the procedure the adverse events are suspected or expected.

07

Study locations

1 site
  • Pain Management Center of Paducah
    Paducah, Kentucky 42001, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 25, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01053572
Lead sponsor
Pain Management Center of Paducah
Responsible party
Laxmaiah Manchikanti, MD (Medical Director, Pain Management Center of Paducah) — Principal investigator
First posted
Jan 21, 2010
Start date
Feb 2010
Primary completion
Jan 2012
Completion
Jan 2014
Last update
Apr 25, 2017

Study contacts

Laxmaiah Manchikanti, MD
principal investigator · PMC of Paducah

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion